Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

258.45
+3.671.44%
Post-market: 258.25-0.1988-0.08%17:39 EDT
Volume:5.39M
Turnover:1.40B
Market Cap:622.68B
PE:29.93
High:260.68
Open:256.21
Low:255.73
Close:254.78
52wk High:281.07
52wk Low:182.94
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.65
T/O Rate:0.22%
Dividend:5.24
Dividend Rate:2.03%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.33
PE(LYR):23.42

Loading ...

Earning Preview: Johnson & Johnson this quarter’s revenue is expected to increase by 6.21%, and institutional views are bullish

Earnings Agent
·
Oct 06

3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List

TIPRANKS
·
39 mins ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
46 mins ago

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
5 hours ago

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Yesterday

Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market

Reuters
·
Yesterday

Smaio - Signs Sales Agency Agreement with Depuy Synthes for US Market

THOMSON REUTERS
·
Oct 06

Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says

MT Newswires Live
·
Oct 06

Johnson & Johnson Price Target Raised to $290.00/Share from $287.00 by RBC Capital

Dow Jones
·
Oct 06

Johnson & Johnson price target raised to $290 from $287 at RBC Capital

TIPRANKS
·
Oct 06

RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)

TIPRANKS
·
Oct 06

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR

Reuters
·
Oct 06

L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports

Reuters
·
Oct 06

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

Citigroup Adjusts Price Target on Johnson & Johnson to $303 From $298, Keeps Buy Rating

MT Newswires Live
·
Oct 05

One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet

Bellwether Stocks Movement
·
Oct 05